C. G. Winter - Merck Res Labs, 33 Ave Louis Pasteur, Boston, MA 02115 USA

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 78 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

A Novel Approach for First-in-human Dose Selection Using Population Dose-Response Modelling to Find a Minimum Anticipated Biological Effect Level

Lin Yuan, Meghana Kulkarni, Evan Chiswick, Cheryl Koh, Peter Sandy, Salah Nabhan,Woody Sherman, Melissa Johnson, Judy Wang,Gerald Falchook, Jennifer Johnson,Christopher Winter, Humphrey Gardner,Arijit Chakravarty,Madison Stoddard

British journal of clinical pharmacology (2025)

Cited0Views0WOSBibtex

Supplemental Table 1. Thirty-nine Cell Lines Used in Combination Screen. from an Unbiased Oncology Compound Screen to Identify Novel Combination Strategies

Jennifer O'Neil,Yair Benita,Igor Feldman,Melissa Chenard,Brian Roberts,Yaping Liu,Jing Li,Astrid Kral,Serguei Lejnine,Andrey Loboda,William Arthur,Razvan Cristescu,Brian B. Haines,Christopher Winter,Theresa Zhang,Andrew Bloecher,Stuart D. Shumway

openalex（2023）

Cited0Views0Bibtex

Supplementary Methods, Tables 1 - 4, Figure Legends from Combination of the Mtor Inhibitor Ridaforolimus and the Anti-IGF1R Monoclonal Antibody Dalotuzumab: Preclinical Characterization and Phase I Clinical Trial

Serena Di Cosimo,Sriram Sathyanarayanan, Johanna C. Bendell,Andrés Cervantes, Mark N. Stein, Irene Braña,Desamparados Roda,Brian B. Haines,Theresa Zhang,Christopher G. Winter,Sharda Jha,Youyuan Xu,Jason Frazier,Richard A. Klinghoffer,Ann Leighton-Swayze, Yang Song,Scot Ebbinghaus,José Baselga

openalex（2023）

Cited0Views0Bibtex

Supplementary Figure Legends from an Unbiased Oncology Compound Screen to Identify Novel Combination Strategies

openalex（2023）

Cited0Views0Bibtex

Supplementary Figure 3 from Combination of the Mtor Inhibitor Ridaforolimus and the Anti-IGF1R Monoclonal Antibody Dalotuzumab: Preclinical Characterization and Phase I Clinical Trial

Serena Di Cosimo,Sriram Sathyanarayanan, Johanna C. Bendell,Andrés Cervantes, Mark N. Stein, Irene Braña,Desamparados Roda,Brian B. Haines,Theresa Zhang,Christopher G. Winter,Sharda Jha,Youyuan Xu,Jason Frazier,Richard A. Klinghoffer, Ann Leighton-Swayze, Yang Song,Scot Ebbinghaus,José Baselga

openalex（2023）

Cited0Views0Bibtex

Supplementary Figure 4 from Combination of the Mtor Inhibitor Ridaforolimus and the Anti-IGF1R Monoclonal Antibody Dalotuzumab: Preclinical Characterization and Phase I Clinical Trial

Serena Di Cosimo,Sriram Sathyanarayanan, Johanna C. Bendell,Andrés Cervantes, Mark N. Stein, Irene Braña,Desamparados Roda,Brian B. Haines,Theresa Zhang,Christopher G. Winter,Sharda Jha,Youyuan Xu,Jason Frazier,Richard A. Klinghoffer, Ann Leighton-Swayze, Yang Song,Scot Ebbinghaus,José Baselga

openalex（2023）

Cited0Views0Bibtex

Supplementary Figure 2. Experiment That Was Used to Select Drug Concentrations for Combination Screen. from an Unbiased Oncology Compound Screen to Identify Novel Combination Strategies

openalex（2023）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn